Neuberger Berman Group LLC Biomarin Pharmaceutical Inc Transaction History

Neuberger Berman Group LLC

  • $123 Billion
  • Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Neuberger Berman Group LLC holds 897,579 shares of BMRN stock, worth $60.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
897,579
Previous 1,094,193 17.97%
Holding current value
$60.3 Million
Previous $90.1 Million 29.97%
% of portfolio
0.05%
Previous 0.08%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$69.02 - $93.84 $13.6 Million - $18.5 Million
-196,614 Reduced 17.97%
897,579 $63.1 Million
Q2 2024

Nov 14, 2024
BUY
$74.43 - $92.22 $46.8 Million - $58 Million
628,463 Added 134.94%
1,094,193 $90.1 Million
Q2 2024

Aug 13, 2024
BUY
$74.43 - $92.22 $46.8 Million - $58 Million
628,463 Added 134.94%
1,094,193 $90.1 Million
Q1 2024

Nov 14, 2024
BUY
$83.81 - $99.0 $9.81 Million - $11.6 Million
117,008 Added 33.55%
465,730 $40.7 Million
Q1 2024

May 13, 2024
BUY
$83.81 - $99.0 $39 Million - $46.1 Million
465,730 New
465,730 $40.7 Million
Q4 2023

Nov 14, 2024
SELL
$76.22 - $98.51 $56.8 Million - $73.4 Million
-745,471 Reduced 68.13%
348,722 $33.6 Million
Q4 2023

Feb 09, 2024
BUY
$76.22 - $98.51 $8.24 Million - $10.6 Million
108,094 Added 44.92%
348,722 $33.6 Million
Q3 2023

Nov 14, 2023
BUY
$85.07 - $94.48 $3.41 Million - $3.78 Million
40,032 Added 19.96%
240,628 $21.3 Million
Q2 2023

Aug 11, 2023
BUY
$86.68 - $100.3 $4.03 Million - $4.67 Million
46,549 Added 30.22%
200,596 $17.4 Million
Q1 2023

May 12, 2023
SELL
$87.74 - $117.27 $1.31 Million - $1.76 Million
-14,975 Reduced 8.86%
154,047 $15 Million
Q4 2022

Feb 13, 2023
BUY
$80.93 - $108.63 $176,832 - $237,356
2,185 Added 1.31%
169,022 $17.5 Million
Q3 2022

Nov 15, 2022
BUY
$82.16 - $96.94 $11.4 Million - $13.5 Million
139,356 Added 507.1%
166,837 $14.1 Million
Q2 2022

Aug 15, 2022
SELL
$71.48 - $86.85 $17,298 - $21,017
-242 Reduced 0.87%
27,481 $2.28 Million
Q1 2022

May 13, 2022
SELL
$74.28 - $92.69 $368,725 - $460,113
-4,964 Reduced 15.19%
27,723 $1.95 Million
Q4 2021

Feb 11, 2022
BUY
$71.72 - $91.47 $390,300 - $497,779
5,442 Added 19.97%
32,687 $2.68 Million
Q3 2021

Nov 12, 2021
SELL
$74.77 - $85.47 $402,711 - $460,341
-5,386 Reduced 16.51%
27,245 $1.96 Million
Q2 2021

Aug 13, 2021
SELL
$75.51 - $84.79 $345,080 - $387,490
-4,570 Reduced 12.28%
32,631 $2.58 Million
Q1 2021

May 13, 2021
BUY
$74.73 - $90.69 $103,949 - $126,149
1,391 Added 3.88%
37,201 $2.74 Million
Q4 2020

Feb 10, 2021
SELL
$72.61 - $90.2 $3.06 Million - $3.8 Million
-42,171 Reduced 54.08%
35,810 $3.12 Million
Q3 2020

Nov 12, 2020
SELL
$71.87 - $131.03 $527,813 - $962,284
-7,344 Reduced 8.61%
77,981 $5.93 Million
Q2 2020

Aug 13, 2020
SELL
$79.55 - $124.22 $9.4 Million - $14.7 Million
-118,187 Reduced 58.07%
85,325 $10.5 Million
Q1 2020

May 14, 2020
SELL
$71.37 - $96.85 $244,014 - $331,130
-3,419 Reduced 1.65%
203,512 $17.2 Million
Q4 2019

Feb 12, 2020
BUY
$64.27 - $86.37 $1.68 Million - $2.26 Million
26,156 Added 14.47%
206,931 $17.5 Million
Q3 2019

Nov 13, 2019
SELL
$67.4 - $85.11 $49.6 Million - $62.6 Million
-735,538 Reduced 80.27%
180,775 $12.2 Million
Q2 2019

Aug 13, 2019
SELL
$80.35 - $93.9 $11.1 Million - $13 Million
-138,025 Reduced 13.09%
916,313 $78.5 Million
Q1 2019

May 13, 2019
SELL
$84.2 - $98.62 $18.1 Million - $21.1 Million
-214,426 Reduced 16.9%
1,054,338 $93.7 Million
Q4 2018

Feb 12, 2019
SELL
$80.14 - $106.07 $2.87 Million - $3.79 Million
-35,754 Reduced 2.74%
1,268,764 $108 Million
Q3 2018

Nov 13, 2018
BUY
$93.92 - $105.72 $10.9 Million - $12.3 Million
116,452 Added 9.8%
1,304,518 $126 Million
Q2 2018

Aug 13, 2018
BUY
$76.01 - $99.03 $35.9 Million - $46.7 Million
471,829 Added 65.88%
1,188,066 $112 Million
Q1 2018

May 08, 2018
BUY
$77.67 - $92.63 $31.9 Million - $38.1 Million
411,140 Added 134.76%
716,237 $58.1 Million
Q4 2017

Feb 14, 2018
BUY
$80.76 - $95.13 $14.6 Million - $17.2 Million
181,192 Added 146.23%
305,097 $27.2 Million
Q3 2017

Nov 15, 2017
BUY
$80.6 - $94.95 $9.99 Million - $11.8 Million
123,905
123,905 $11.5 Million

Others Institutions Holding BMRN

# of Institutions
638
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email